SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$11.53
+2.85%
Mkt Cap $1.86B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+116.8%
Consensus $25.00 vs current $11.53
NASDAQ·Healthcare·Biotechnology
$11.53
+2.85%
Mkt Cap $1.86B
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.00
Range $25.00 – $25.00
+116.8%
Consensus $25.00 vs current $11.53